Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Regenerative Medicine
|
May 2, 2015
The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies
Alain A Vertès
Regenerative Medicine
|
December 16, 2017
Methods and practices to diversify cell-based products
Alain A Vertès
Regenerative Medicine
|
August 28, 2014
Deciphering the therapeutic stem cell strategies of large and midsize pharmaceutical firms
Alain A Vertès
Cellular & Molecular Immunology
|
September 14, 2019
TOX: a rediscovered master molecular actor to enhance immuno-oncology interventions
Alain A Vertès
Regenerative Medicine
|
May 2, 2015
The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs
Alain A Vertès
Frontiers in Bioengineering and Biotechnology
|
February 12, 2026
Editorial: Clinical translation and commercialisation of advanced therapy medicinal products, volume II
Yves Bayon, Alain A Vertès
Journal of Molecular Microbiology and Biotechnology
|
March 20, 2008
Technological options for biological fuel ethanol
Alain A Vertès, Masayuki Inui, Hideaki Yukawa
Applied and Environmental Microbiology
|
December 8, 2005
Manipulating corynebacteria, from individual genes to chromosomes
Alain A Vertès, Masayuki Inui, Hideaki Yukawa
Annual Review of Microbiology
|
July 19, 2012
Postgenomic approaches to using corynebacteria as biocatalysts
Alain A Vertès, Masayuki Inui, Hideaki Yukawa
Nature Biotechnology
|
July 15, 2006
Implementing biofuels on a global scale
Alain A Vertès, Masayuki Inui, Hideaki Yukawa
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Regenerative Medicine
|
May 2, 2015
The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies
Alain A Vertès
Regenerative Medicine
|
December 16, 2017
Methods and practices to diversify cell-based products
Alain A Vertès
Regenerative Medicine
|
August 28, 2014
Deciphering the therapeutic stem cell strategies of large and midsize pharmaceutical firms
Alain A Vertès
Cellular & Molecular Immunology
|
September 14, 2019
TOX: a rediscovered master molecular actor to enhance immuno-oncology interventions
Alain A Vertès
Regenerative Medicine
|
May 2, 2015
The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs
Alain A Vertès
Frontiers in Bioengineering and Biotechnology
|
February 12, 2026
Editorial: Clinical translation and commercialisation of advanced therapy medicinal products, volume II
Yves Bayon, Alain A Vertès
Journal of Molecular Microbiology and Biotechnology
|
March 20, 2008
Technological options for biological fuel ethanol
Alain A Vertès, Masayuki Inui, Hideaki Yukawa
Applied and Environmental Microbiology
|
December 8, 2005
Manipulating corynebacteria, from individual genes to chromosomes
Alain A Vertès, Masayuki Inui, Hideaki Yukawa
Annual Review of Microbiology
|
July 19, 2012
Postgenomic approaches to using corynebacteria as biocatalysts
Alain A Vertès, Masayuki Inui, Hideaki Yukawa
Nature Biotechnology
|
July 15, 2006
Implementing biofuels on a global scale
Alain A Vertès, Masayuki Inui, Hideaki Yukawa
Page
of 3